carmustine has been researched along with bromopyruvate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y; Peng, Y; Sun, G; Sun, X; Tang, X; Zhang, N; Zhang, S; Zhao, L; Zhong, R | 1 |
| Hao, Y; Huang, Y; Peng, Y; Sun, G; Sun, X; Tang, X; Zhang, N; Zhao, L; Zhong, R | 1 |
2 other study(ies) available for carmustine and bromopyruvate
| Article | Year |
|---|---|
Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation.
Topics: Adenosine Triphosphate; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cell Line, Tumor; DNA Damage; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance; Glioma; Glutathione; Glycolysis; Humans; O(6)-Methylguanine-DNA Methyltransferase; Pyruvates; Tumor Suppressor Proteins | 2020 |
3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents, Alkylating; Carmustine; Cell Line, Tumor; Cross-Linking Reagents; DNA; DNA Damage; DNA Repair; DNA, Neoplasm; Drug Combinations; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Glutathione; Glycolysis; Hep G2 Cells; Hexokinase; Humans; O(6)-Methylguanine-DNA Methyltransferase; Pyruvates | 2020 |